Any decision about an actual dose belongs with a qualified clinician
At this time, GLP-1 microdosing has not been proven to prevent cognitive decline, improve memory, or protect against dementia
Matt Williams: Yeah, every class, the claims are different, the damages might be different
Even though patients are often taking the exact same drug at the same or slightly adjusted doses, what changes is how they want to buy it and the level of care associated with it, and I think this explains why many customers switch and migrate to simpler, more transactional services where they can get their medication without the ankle-monitor and simply get on with their lives
Werner JA, Davies R, Wahlstrom J, Dahal UP, Jiang M, Stauber J, et al